Abstract | OBJECTIVE: METHODS: RESULTS: The clinical cure rates of the oral administration groups were 56.76% - 62.50%, all significantly lower than those of the oral/vaginal combination groups (80.00% - 86.11%, all P < 0.05). There was nit significantly difference in efficacy level among the only oral treatment groups and the oral/vaginal combination groups (all P > 0.05). CONCLUSION:
|
Authors | Feng-Mei Wang, Xiao-Dan Qian, Hong Xu, He-Yong Yu |
Journal | Zhonghua yi xue za zhi
(Zhonghua Yi Xue Za Zhi)
Vol. 88
Issue 31
Pg. 2201-3
(Aug 12 2008)
ISSN: 0376-2491 [Print] China |
PMID | 19080672
(Publication Type: English Abstract, Journal Article, Randomized Controlled Trial)
|
Chemical References |
- Delayed-Action Preparations
- Nitroimidazoles
- Tablets
- Tinidazole
- Metronidazole
- Ornidazole
- secnidazole
|
Topics |
- Administration, Intravaginal
- Administration, Oral
- Adult
- Delayed-Action Preparations
- Drug Administration Schedule
- Drug Therapy, Combination
- Female
- Humans
- Metronidazole
(administration & dosage, analogs & derivatives, therapeutic use)
- Nitroimidazoles
(administration & dosage, therapeutic use)
- Ornidazole
(administration & dosage, therapeutic use)
- Prospective Studies
- Tablets
- Tinidazole
(administration & dosage, therapeutic use)
- Treatment Outcome
- Vaginosis, Bacterial
(drug therapy)
- Young Adult
|